Is Endo Pharmaceuticals a good stock to buy?

Is Endo Pharmaceuticals a good stock to buy?

Endo International has received a consensus rating of Hold. The company’s average rating score is 2.00, and is based on 1 buy rating, 2 hold ratings, and 1 sell rating.

Is Endo international stock a buy?

Out of 4 analysts, 1 (25%) are recommending ENDP as a Strong Buy, 0 (0%) are recommending ENDP as a Buy, 2 (50%) are recommending ENDP as a Hold, 0 (0%) are recommending ENDP as a Sell, and 1 (25%) are recommending ENDP as a Strong Sell. What is ENDP’s earnings growth forecast for 2022-2024?

Is Endo aesthetics a publicly traded company?

Endo International plc is an American Irish-domiciled generics and specialty branded pharmaceutical company that generated over 93% of its 2017 sales from the U.S. healthcare system….Endo International.

Is Endo a good company?

Is Endo Pharmaceuticals a good company to work for? Endo Pharmaceuticals has an overall rating of 3.8 out of 5, based on over 247 reviews left anonymously by employees. 82% of employees would recommend working at Endo Pharmaceuticals to a friend and 61% have a positive outlook for the business.

Is ENDP stock a good buy?

Endo International PLC (NASDAQ:ENDP) The 4 analysts offering 12-month price forecasts for Endo International PLC have a median target of 2.50, with a high estimate of 4.00 and a low estimate of 1.50. The median estimate represents a +22.85% increase from the last price of 2.04.

What is VGM Score?

We also produce the VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual Style Scores into one score. This is perfectly suited for those who want their stocks to have the best scores across the board.

What is the price targets for Endo International’s stock?

Their forecasts range from $2.00 to $15.00. On average, they expect Endo International’s share price to reach $7.42 in the next year. This suggests a possible upside of 55.2% from the stock’s current price. View Analyst Price Targets for Endo International.

What is the all-time high Endo stock price?

The all-time high Endo stock closing price was 95.92 on April 15, 2015. The Endo 52-week high stock price is 10.89, which is 156.2% above the current share price.

Does Endo International plc own Par Pharmaceuticals?

DUBLIN, Jan. 4, 2022 /PRNewswire/ — Endo International plc (NASDAQ: ENDP) announced today that one of its operating companies, Par Pharmaceutical, Inc. (Par), has begun shipping the first generic versi…

How much money does Endo make a year?

Endo International has a market capitalization of $549.13 million and generates $2.90 billion in revenue each year. The company earns $183.94 million in net income (profit) each year or $0.28 on an earnings per share basis. How many employees does Endo International have?